1nak:L     (VAL3) to   (ILE106)  IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1nak:M     (VAL3) to   (ILE106)  IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1a5f:L     (ASP1) to   (LEU112)  FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY  |   IMMUNOGLOBULIN, FAB, ANTIBODY, ANTI-E-SELECTIN 
1a6w:L     (ALA2) to   (LEU109)  B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND  |   IMMUNOGLOBULIN, HAPTEN 
1a7p:L     (ILE2) to   (ILE106)  FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) ENGINEERED MUTANT PRO95L->SER ON VARIANT CHAIN L GLU81- >ASP AND CHAIN H LEU312->VAL  |   IMMUNOGLOBULIN, VARIANT 
1a7q:L     (ASP1) to   (ILE106)  FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) HIGH AFFINITY EXPRESSED VARIANT CONTAINING SER26L->GLY, ILE29L->THR, GLU81L->ASP, THR97L->SER, PRO240H->LEU, ASP258H->ALA, LYS281H->GLU, ASN283H->ASP AND LEU312H->VAL  |   IMMUNOGLOBULIN, VARIANT 
1a7r:L     (ASP1) to   (ILE106)  FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT CHAIN L GLU81->ASP  |   IMMUNOGLOBULIN, VARIANT 
4wht:J     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:B     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:D     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:F     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:H     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:L     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:N     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:P     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:R     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:T     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:V     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:Y     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:H     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:J     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:L     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:N     (ASP1) to   (LEU110)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
1ngq:L     (ALA2) to   (LEU109)  N1G9 (IGG1-LAMBDA) FAB FRAGMENT  |   IMMUNOGLOBULIN, 
1acy:L     (VAL3) to   (ALA109)  CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 1  |   COMPLEX(ANTIBODY/HIV-1 FRAGMENT) 
1nqb:C   (ILE122) to   (ILE231)  TRIVALENT ANTIBODY FRAGMENT  |   ANTIBODY FRAGMENT, MULTIVALENT ANTIBODY, DIABODY, DOMAIN SWAPPING, IMMUNOGLOBULIN 
1ap2:C     (ILE2) to   (PRO112)  SINGLE CHAIN FV OF C219  |   SINGLE CHAIN FV, MONOCLONAL ANTIBODY, C219, P-GLYCOPROTEIN, IMMUNOGLOBULIN 
3eo9:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB  |   EFALIZUMAB, FAB, ANTIBODY, IMMUNE SYSTEM 
4h8w:L     (LEU5) to   (VAL106)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.  |   HIV-1 GP120, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1b2w:L     (GLN3) to   (VAL106)  COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY  |   ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, THREE- DIMENSIONAL STRYCTURE, GAMMA-INTERFERON, IMMUNE SYSTEM 
3esv:F     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18  |   SINGLE-CHAIN FV, MONOCLONAL ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3esv:G     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18  |   SINGLE-CHAIN FV, MONOCLONAL ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3etb:F     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18 COMPLEXED WITH ANTHRAX PROTECTIVE ANTIGEN DOMAIN 4  |   SINGLE-CHAIN FV, MONOCLONAL ANTIBODY, IMMUNOGLOBULIN, TOXIN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM/TOXIN COMPLEX 
3etb:H     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18 COMPLEXED WITH ANTHRAX PROTECTIVE ANTIGEN DOMAIN 4  |   SINGLE-CHAIN FV, MONOCLONAL ANTIBODY, IMMUNOGLOBULIN, TOXIN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM/TOXIN COMPLEX 
4wy7:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF RECOMBINANT 4E10 EXPRESSED IN ESCHERICHIA COLI WITH EPITOPE BOUND  |   BROAD NEUTRALIZING ANTOBODY, RECOMBINANT FAB, EPITOPE, IMMUNE SYSTEM 
3s36:L     (ASP1) to   (ILE106)  STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES  |   ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
4hlz:L     (ILE4) to   (ILE108)  CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H2N2 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4x4z:B     (ILE2) to   (ILE106)  RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN VL MUTANT F53D.  |   ANTIBODY STABILIZATION MUTATIONS, IMMUNE SYSTEM 
1bvk:A     (ASP1) to   (ILE106)  HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME  |   HUMANIZED ANTIBODY, ANTIBODY COMPLEX, FV, ANTI-LYSOZYME, COMPLEX (HUMANIZED ANTIBODY/HYDROLASE) 
4xaw:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA)  |   HIV-1 GP41 MPER, 4E10 FAB, LIPID MEMBRANE, IMMUNE SYSTEM 
4xbe:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).  |   HIV-1 GP41 MPER, 4E10 FAB, MEMBRANE LIPID, IMMUNE SYSTEM 
4xbg:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbg:D     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbg:I     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbp:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)  |   HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM 
4xbp:B     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)  |   HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM 
4xc1:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE  |   HIV-1 GP41 MPER, 4E10 FAB, LIPID MEMBRANE, IMMUNE SYSTEM 
2bx5:D     (ILE2) to   (ILE106)  IS FR1 THE ANTIBODY'S ACHILLIES HEEL  |   IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1 
4xcc:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP  |   4E10 FAB ANTI HIV-1 GP41, LIPID MEMBRANE, IMMUNE SYSTEM, PHOSPHATIDYLCHOLINE 
4xce:B     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP  |   4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM 
4xce:D     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP  |   4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM 
2c1p:A     (LEU2) to   (LEU106)  FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE  |   FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENANTIOSELECTIVE ANTIBODY, IMMUNOGLOBULIN DOMAIN 
1cfq:A     (ILE2) to   (LEU106)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
3fo0:L     (GLU1) to   (ILE111)  CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4xnm:L     (TYR1) to   (VAL104)  ANTIBODY INFLUENZA H5 COMPLEX  |   ANTIBODY, INFLUENZA, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1dlf:L     (VAL3) to   (GLU105)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 5.25  |   FV FRAGMENT, IMMUNOGLOBULIN 
3t3m:F     (ILE2) to   (ILE106)  A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS  |   INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET 
1plg:L     (VAL2) to   (ILE111)  EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)- POLYSIALIC ACID  |   IMMUNOGLOBULIN 
1pw3:A     (ASN1) to   (VAL106)  CRYSTAL STRUCTURE OF JTOR68S  |   LIGHT CHAIN, AMYLOIDOSIS, IMMUNE SYSTEM 
1e4w:L     (GLN3) to   (ILE106)  CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT  |   IMMUNE SYSTEM, COMPLEX (ANTIBODY/ANTIGEN), CROSS-REACTIVITY, PROTEIN-PEPTIDE RECOGNITION 
1e4x:M     (GLN3) to   (ILE106)  CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT  |   IMMUNE SYSTEM, COMPLEX (ANTIBODY/ANTIGEN), CROSS-REACTIVITY, PROTEIN-PEPTIDE RECOGNITION 
2dlf:L     (VAL2) to   (ILE106)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75  |   FV FRAGMENT, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2dqt:L     (VAL2) to   (ILE106)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2dqu:L     (VAL2) to   (ILE106)  CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4jfx:L     (ILE2) to   (ILE106)  STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE  |   IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jfy:A     (VAL3) to   (ILE106)  APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD  |   IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jfy:L     (VAL3) to   (ILE106)  APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD  |   IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1qkz:L     (VAL3) to   (ILE106)  FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G  |   IMMUNE SYSTEM, FAB, PORA, NEISSERIA MENINGITIDIS, PORIN 
1qlr:A     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ  |   IMMUNOGLOBULIN, AUTOANTIBODY, COLD AGGLUTININ, HUMAN IGM FAB FRAGMENT 
1qlr:C     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ  |   IMMUNOGLOBULIN, AUTOANTIBODY, COLD AGGLUTININ, HUMAN IGM FAB FRAGMENT 
4jn2:A     (VAL3) to   (ILE112)  AN ANTIDOTE FOR DABIGATRAN  |   IGG FRAGMENT BINDING DABIGATRAN, DABIGATRAN, IMMUNE SYSTEM-INHIBITOR COMPLEX 
4jn2:L     (VAL4) to   (ILE112)  AN ANTIDOTE FOR DABIGATRAN  |   IGG FRAGMENT BINDING DABIGATRAN, DABIGATRAN, IMMUNE SYSTEM-INHIBITOR COMPLEX 
3h3p:M     (GLU1) to   (VAL107)  CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX  |   EPITOPE-SCAFFOLD FV COMPLEX, IMMUNE SYSTEM 
4ygv:B     (ASP1) to   (THR114)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4ygv:L     (ASP1) to   (THR114)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
3twc:L     (ALA3) to   (THR105)  CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9  |   FAB, HIV-1 NEUTRALIZING ANTIBODY, GP120, IMMUNE SYSTEM 
1ezv:Y     (ASP1) to   (ILE106)  STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO- CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT  |   CYTOCHROME BC1 COMPLEX, COMPLEX III, QCR, MITOCHONDRIA, YEAST, ANTIBODY FV-FRAGMENT, STIGMATELLIN, COENZYME Q6, MATRIX PROCESSING PEPTIDASES, UBIQUINONE, ELECTRON TRANSFER, PROTON TRANSFER, Q-CYCLE, OXIDOREDUCTASE/ELECTRON TRANSPORT COMPLEX 
4yhi:B     (ASP1) to   (ILE111)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhi:L     (ASP1) to   (ILE111)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhl:L     (ASP1) to   (ILE111)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhm:L     (ILE2) to   (ILE111)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhn:B     (ASP1) to   (THR114)  DABIGATRAN REVERSAL AGENT  |   ANTIBODIES, IMMUNE SYSTEM 
4yhn:L     (ASP1) to   (THR114)  DABIGATRAN REVERSAL AGENT  |   ANTIBODIES, IMMUNE SYSTEM 
4yho:L     (ASP1) to   (ILE111)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhp:B     (TYR2) to   (THR110)  CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM 
4yhp:L     (TYR2) to   (VAL107)  CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM 
4yhy:C     (LEU4) to   (VAL107)  CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS  |   ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM 
4yhy:L     (LEU4) to   (VAL107)  CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS  |   ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM 
1fe8:L     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING  |   COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM 
1fe8:M     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING  |   COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM 
1fe8:N     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING  |   COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM 
4jzo:F     (TYR2) to   (THR108)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27  |   FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3u9u:B     (LEU3) to   (ILE111)  CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479  |   CELL SURFACE RECEPTOR, TRANSFERASE, TYROSINE KINASE RECEPTOR 
3u9u:D     (LEU3) to   (ILE111)  CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479  |   CELL SURFACE RECEPTOR, TRANSFERASE, TYROSINE KINASE RECEPTOR 
3uaj:L     (GLU2) to   (ILE107)  CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3uaj:D     (GLU2) to   (ILE107)  CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1fgv:L     (GLN3) to   (ILE106)  X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1fj1:A     (ILE2) to   (ILE106)  LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2  |   OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM 
1fj1:C     (ILE2) to   (ILE106)  LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2  |   OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM 
4k2u:L     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT  |   DBL DOMAIN, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, CELL ATTACHMENT, IMMUNITY, RECEPTOR, LIGAND, EXTRACELLULAR, IMMUNE SYSTEM 
1fns:L     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4  |   VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, COMPLEX (WILLEBRAND-IMMUNOGLOBULIN), BLOOD COAGULATION TYPE 2B VON WILLEBRAND DISEASE, IMMUNE SYSTEM 
2v7h:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT  |   MONOCLONAL ANTIBODY, MANNOPYRANOSIDE SPECIFICITY, MOLECULAR MIMICRY, IMMUNE SYSTEM 
2v7h:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT  |   MONOCLONAL ANTIBODY, MANNOPYRANOSIDE SPECIFICITY, MOLECULAR MIMICRY, IMMUNE SYSTEM 
1fvc:C     (ILE2) to   (ILE106)  X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING  |   IMMUNOGLOBULIN 
3uls:A     (SER2) to   (VAL106)  CRYSTAL STRUCTURE OF FAB12  |   TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3hns:L     (ASP1) to   (ILE106)  CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE  |   ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM 
3hnt:L     (ASP1) to   (ILE106)  CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN  |   ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM 
3hnv:L     (ASP1) to   (ILE106)  CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)  |   ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM 
2vdp:L     (ILE2) to   (ILE106)  INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE,LGGAKQAGDV  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
1g7i:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F)  |   HYDROLASE INHIBITOR/HYDROLASE 
2vit:A     (ALA2) to   (LEU109)  INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (HEMAGGLUTININ/IMMMUNOGLOBULIN), GLYCOPROTEIN 
4z7q:F     (ILE2) to   (ILE106)  INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE  |   CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
2fx8:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx8:O     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx9:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx9:M     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
1gpo:L     (ASP1) to   (ALA114)  CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT  |   PROTEIN ENGINEERING, ANTIBODY DESIGN, IMMUNOGLOBULIN STRUCTURE, ANTIGEN-BINDING SITE, CANONICAL CONFORMATION, COMPLEMENTARITY- DETERMINING REGION, IMMUNE SYSTEM 
2vq1:A     (VAL2) to   (ALA109)  ANTI TRIMERIC LEWIS X FAB54-5C10-A  |   MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM 
2vq1:E     (VAL2) to   (ILE106)  ANTI TRIMERIC LEWIS X FAB54-5C10-A  |   MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM 
2g75:B     (TYR3) to   (VAL106)  CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY  |   SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM 
2vxs:L     (ASN1) to   (VAL106)  STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY  |   EPITOPE, COMPLEX, ANTIBODY, SECRETED, CYTOKINE, GLYCOPROTEIN, INTERLEUKIN-17 
2vxs:M     (ASN1) to   (VAL106)  STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY  |   EPITOPE, COMPLEX, ANTIBODY, SECRETED, CYTOKINE, GLYCOPROTEIN, INTERLEUKIN-17 
2vxt:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB  |   FAB, IL-18, SECRETED, CYTOKINE, AUTOIMMUNITY, GLYCOPROTEIN, TH1/TH2 CELLS, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
2vxu:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT  |   FAB, IL-18, AUTOIMMUNITY, TH1/TH2 CELLS, IMMUNE SYSTEM 
2w0l:A     (ASN1) to   (VAL106)  CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2  |   FIBRILS, GERM LINE, ANTIBODIES, FIBRINOGENIC, IMMUNE SYSTEM 
2w0l:B     (ASN1) to   (THR105)  CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2  |   FIBRILS, GERM LINE, ANTIBODIES, FIBRINOGENIC, IMMUNE SYSTEM 
2w0l:C     (ASN1) to   (VAL106)  CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2  |   FIBRILS, GERM LINE, ANTIBODIES, FIBRINOGENIC, IMMUNE SYSTEM 
2w0l:D     (ASN1) to   (VAL106)  CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2  |   FIBRILS, GERM LINE, ANTIBODIES, FIBRINOGENIC, IMMUNE SYSTEM 
2gsi:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE  |   FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM 
1tqc:C     (VAL2) to   (ILE106)  OVINE RECOMBINANT PRP(114-234), ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)  |   PRION, ANTIBODY, UNKNOWN FUNCTION/IMMUNE SYSTEM COMPLEX 
3iy4:A     (LEU1) to   (THR108)  VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 15 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 15 COMPLEX  |   CRYOEM, NEUTRALIZING ANTIBODY, PARVOVIRUS, CANINE, FELINE, FAB FOOTPRINT, IMMUNE SYSTEM 
2hkh:L     (VAL2) to   (ILE111)  CRYSTAL STRUCTURE OF THE FAB M75  |   IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM 
1tzg:L     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41  |   ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
1tzg:M     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41  |   ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
3w14:Q     (ILE2) to   (ILE106)  INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14  |   CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
4lu5:L     (VAL2) to   (ILE111)  STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS  |   IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM 
4m8q:B     (GLU1) to   (GLU105)  ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10  |   HIV, 4E10, GEP, GERMLINE, FV, IMMUNOGLOBULIN, ANTIBODY, 4E10 EPITOPE, IMMUNE SYSTEM 
4m8q:L     (GLU1) to   (GLU105)  ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10  |   HIV, 4E10, GEP, GERMLINE, FV, IMMUNOGLOBULIN, ANTIBODY, 4E10 EPITOPE, IMMUNE SYSTEM 
4m93:L     (ILE2) to   (LEU106)  UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB  |   CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4ma1:C     (ILE2) to   (LEU106)  UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB  |   CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4ma7:L     (VAL3) to   (LEU106)  CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE  |   IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, MOUSE PRION PROTEIN, IMMUNE SYSTEM 
3wfh:B     (VAL2) to   (LEU111)  CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX  |   IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, FAB FRAGMENT BY PAPAIN DIGESTION, IMMUNE SYSTEM 
3whx:B     (VAL2) to   (LEU111)  CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE1 COMPLEX  |   IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, IMMUNE SYSTEM 
3wih:L     (ASP1) to   (LEU106)  CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.  |   FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM 
3wih:M     (ILE2) to   (LEU106)  CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.  |   FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM 
3wif:B     (VAL2) to   (LEU111)  CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT 9CL-PGF2BETA COMPLEX  |   IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, IMMUNE SYSTEM 
2ipu:K     (VAL2) to   (LEU106)  PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE  |   WWDDD, CDR, ABETA, IMMUNE SYSTEM 
2iqa:L     (VAL2) to   (ILE106)  PFA2 FAB FRAGMENT, MONOCLINIC APO FORM  |   PFA2, WWDDD, CDR, IMMUNE SYSTEM 
2iqa:A     (VAL2) to   (ILE106)  PFA2 FAB FRAGMENT, MONOCLINIC APO FORM  |   PFA2, WWDDD, CDR, IMMUNE SYSTEM 
1jgu:L     (VAL3) to   (LEU106)  STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4  |   IGG FOLD, IMMUNE SYSTEM 
1jgv:L     (VAL3) to   (LEU106)  STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4  |   IGG FOLD, IMMUNE SYSTEM 
1vfa:A     (ASP1) to   (ILE106)  BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION  |   IMMUNOGLOBULIN 
5aum:B     (VAL2) to   (ILE106)  CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE  |   ANTIBODY, PEPTIDE LIGAND, PROTEASE, ELISA, WESTERN BLOTTING, IMMUNE SYSTEM-PEPTIDE COMPLEX 
5aum:L     (VAL2) to   (ILE106)  CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE  |   ANTIBODY, PEPTIDE LIGAND, PROTEASE, ELISA, WESTERN BLOTTING, IMMUNE SYSTEM-PEPTIDE COMPLEX 
1jp5:B     (ILE2) to   (ILE111)  CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-1 PROTEASE  |   ANTIBODY-ANTIGEN COMPLEX, HIV PR INHIBITING ANTIBODY, IMMUNE SYSTEM 
5aze:L     (SER2) to   (VAL110)  FAB FRAGMENT OF CALCIUM-DEPENDENT ANTIGEN BINDING ANTIBODY, 6RL#9  |   CALCIUM-DEPENDENT, RECYCLING ANTIBODY, IMMUNE SYSTEM 
2jel:L     (LEU3) to   (ALA109)  JEL42 FAB/HPR COMPLEX  |   ANTIBODY-PROTEIN COMPLEX, HISTIDINE-CONTAINING PROTEIN, MOLECULAR RECOGNITION, COMPLEX (ANTIBODY/ANTIGEN) 
3zdx:F     (ILE2) to   (ILE106)  INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX 
1kiq:A     (ILE2) to   (ILE106)  FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME  |   IMMUNOGLOBULIN V REGION, SIGNAL, HYDROLASE, GLYCOSIDASE, BACTERIOLYTIC ENZYME, EGG WHITE, COMPLEX (IMMUNOGLOBULIN/HYDROLASE) 
1wz1:L     (VAL2) to   (ILE111)  CRYSTAL STRUCTURE OF THE FV FRAGMENT COMPLEXED WITH DANSYL- LYSINE  |   ANTIGEN-ANTIBODY FRAGENT COMPLEX, IMMUNE SYSTEM 
4o02:L     (ASP1) to   (MET106)  ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.  |   PROTEIN BINDING 
1kyo:K     (GLU3) to   (ILE106)  YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C  |   MULTISUBUNIT MEMBRANE PROTEIN COMPLEX, ENZYME SUBSTRATE COMPLEX, ELECTRON TRANSFER COMPLEX, ANTIBODY FV FRAGMENT MEDIATED CRYSTALLIZATION, OXIDOREDUCTASE/ELECTRON TRANSPORT COMPLEX 
1kyo:V     (GLU3) to   (ILE106)  YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C  |   MULTISUBUNIT MEMBRANE PROTEIN COMPLEX, ENZYME SUBSTRATE COMPLEX, ELECTRON TRANSFER COMPLEX, ANTIBODY FV FRAGMENT MEDIATED CRYSTALLIZATION, OXIDOREDUCTASE/ELECTRON TRANSPORT COMPLEX 
43ca:G     (VAL2) to   (LYS107)  CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY 
2nr6:E     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2  |   BLA G 2, FAB, HYDROLASE-IMMUNE SYSTEM COMPLEX 
2yss:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HQ39KW47Y)-HEN LYSOZYME COMPLEX  |   IMMUNE SYSTEM, HYDROLASE, IMMUNE SYSTEM/HYDROLASE COMPLEX 
5cil:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (WDWD) WITH EPITOPE BOUND  |   BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM 
5cin:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (DELTALOOP) WITH EPITOPE BOUND  |   BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM 
4ocy:L     (LEU3) to   (LEU111)  FAB FOR METHOTREXATE (UNBOUND APO)  |   IGG1/K FAMILY, IMMUNE SYSTEM 
4odw:L     (ILE2) to   (ILE106)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
4odw:B     (ILE2) to   (ILE106)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
4okv:D     (VAL3) to   (ILE111)  CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY  |   MALARIA VECTOR MOSQUITO, COLLAGEN BINDING PROTEIN, BLOOD CLOTTING 
1m7d:A     (VAL2) to   (ILE106)  CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE  |   FAB-CARBOHYDRATE INTERACTIONS, SHIGELLA O-ANTIGEN, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
1m7i:A     (VAL2) to   (ILE106)  CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE  |   FAB-CARBOHYDRATE INTERACTIONS; SHIGELLA O-ANTIGEN; AND ANTI- CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
5czv:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20350 FAB  |   ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM 
5czx:L     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB  |   ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM 
1mcq:B     (LEU4) to   (VAL109)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
3klh:C     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)  |   HIV-1, REVERSE TRANSCRIPTASE, RT, AZT, AZT EXCISION, AZT RESISTANCE, RESISTANCE MECHANISM, AZT RESISTANCE MUTATIONS, P51/P66, NUCLEOSIDE INHIBITOR, AIDS, HIV, DNA POLYMERASE, NRTI, NUCLEOTIDE EXCISION, DNA-DIRECTED DNA POLYMERASE, MAGNESIUM, METAL-BINDING, MULTIFUNCTIONAL ENZYME, NUCLEASE, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE, TRANSFERASE-DNA COMPLEX 
1mlc:A     (ILE2) to   (ILE106)  MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME  |   COMPLEX (ANTIBODY/ANTIGEN) 
1mnu:L     (ILE2) to   (ILE111)  UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS  |   MURINE IMMUNOGLOBULIN IGG2A KAPPA, BACTERICIDAL ANTIBODY, EPITOPE P1.16 OF PORA FROM NEISSERIA MENINGITIDIS, UNLIGANDED, IMMUNE SYSTEM 
1mre:L     (VAL2) to   (ALA109)  PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES  |   IMMUNOGLOBULIN 
4pd4:K     (ILE2) to   (ILE106)  STRUCTURAL ANALYSIS OF ATOVAQUONE-INHIBITED CYTOCHROME BC1 COMPLEX REVEALS THE MOLECULAR BASIS OF ANTIMALARIAL DRUG ACTION  |   CYTOCHROME BC1 COMPLEX, MEMBRANE PROTEIN COMPLEX, ANTIMALARIAL DRUG, INHIBITOR, OXIDOREDUCTASE-INHIBITOR COMPLEX 
5dfw:H   (GLN503) to   (ILE809)  CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH SINGLE CHAIN FV FRAGMENT K13  |   HELICAL BUNDLE, ANTIBODY-ANTIGEN COMPLEX, CELL ADHESION 
4pp1:C     (ASP1) to   (ILE105)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
4pp1:E     (ASP1) to   (ILE105)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
3lh2:L     (ILE2) to   (VAL107)  CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX  |   EPITOPE-SCAFFOLD, IMMUNE SYSTEM 
3lh2:N     (ILE2) to   (VAL107)  CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX  |   EPITOPE-SCAFFOLD, IMMUNE SYSTEM 
5drw:B     (VAL2) to   (ILE112)  CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL183  |   IMMUNOGLOBULIN FOLD, B-CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX 
5drx:L     (ILE2) to   (ILE112)  CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL240  |   IMMUNOGLOBULIN FOLD, B CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX 
4q0x:L     (ASP1) to   (ILE111)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2  |   ANTIBODY, ANTI-HCV E2, HCV E2, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4at6:D     (ALA2) to   (LEU109)  FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7  |   IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE 
4at6:F     (ALA2) to   (LEU109)  FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7  |   IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE 
3auv:E    (GLN14) to   (ILE117)  PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE  |   SC-DSFV (DISULFIDE-STABILIZED SCFV), SCFV, MONOVALENT ANTIBODY, VEGF, ANTIBODY ENGINEERING, IMMUNE SYSTEM 
2a1w:L     (LEU3) to   (SER111)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I  |   IMMUNE SYSTEM 
2a1w:M     (LEU3) to   (SER111)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I  |   IMMUNE SYSTEM 
2a6d:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE  |   GERMLINE, FAB, ANTIBODY, IMMUNE SYSTEM 
2a6i:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL  |   IMMUNOGLOBULIN FOLD, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
3b2u:G     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8  |   CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
3b2u:O     (GLU1) to   (ILE106)  CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8  |   CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
3mj8:L     (TYR2) to   (GLN108)  CRYSTAL STRUCTURE OF HL4E10 FAB, A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS  |   ANTIBODY, HAMSTER IGG, IMMUNE SYSTEM 
5eoq:L     (VAL2) to   (ALA114)  STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40  |   ANTIBODY, FAB, VACCINIA VIRUS, NEUTRALIZING, LINEAR EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5epm:B     (VAL2) to   (ALA114)  CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT  |   CERATOTOXIN, RANDOM MUTAGENESIS, NAV1.7 ION CHANEL, TOXIN-IMMUNE SYSTEM COMPLEX 
5epm:F     (VAL2) to   (ALA114)  CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT  |   CERATOTOXIN, RANDOM MUTAGENESIS, NAV1.7 ION CHANEL, TOXIN-IMMUNE SYSTEM COMPLEX 
4bh7:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE PPYPAWHAPGNI  |   IMMUNE SYSTEM, CONVERGENCE OF ANTIBODY SPECIFICITIES 
5esv:B     (GLU1) to   (LEU106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.  |   HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM 
4qth:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12  |   ANTIBODY, IMMUNE SYSTEM 
3cfj:A     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfj:E     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3nid:F     (ILE2) to   (ILE106)  THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX 
3nid:L     (ILE2) to   (ILE106)  THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX 
3nif:F     (ILE2) to   (ILE106)  THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX 
3nig:F     (ILE2) to   (ILE106)  THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-IMMUNE SYSTEM COMPLEX, CELL ADHESION-BLOOD CLOTTING COMPLEX 
4cad:A     (GLN3) to   (LEU106)  MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1  |   PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT 
4cmh:C     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984  |   HYDROLASE-IMMUNE SYSTEM COMPLEX, MULTIPLE MYELOMA 
3cx5:K     (ILE2) to   (ILE106)  STRUCTURE OF COMPLEX III WITH BOUND CYTOCHROME C IN REDUCED STATE AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.  |   COMPLEX III, CYTOCHROME C, ELECTRON TRANSFER COMPLEX, CYTOCHROME BC1 COMPLEX, MITOCHONDRIALTRANSMEMBRANE COMPLEX, RESPIRATORY CHAIN, TRANSIENT PROTEIN-PROTEIN INTERACTION, ELECTRON TRANSPORT, INNER MEMBRANE, MITOCHONDRION, TRANSIT PEPTIDE, TRANSPORT, PHOSPHOPROTEIN, HEME, IRON, METAL-BINDING, IRON-SULFUR, OXIDOREDUCTASE, METHYLATION 
3cx5:V     (GLU3) to   (ILE106)  STRUCTURE OF COMPLEX III WITH BOUND CYTOCHROME C IN REDUCED STATE AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.  |   COMPLEX III, CYTOCHROME C, ELECTRON TRANSFER COMPLEX, CYTOCHROME BC1 COMPLEX, MITOCHONDRIALTRANSMEMBRANE COMPLEX, RESPIRATORY CHAIN, TRANSIENT PROTEIN-PROTEIN INTERACTION, ELECTRON TRANSPORT, INNER MEMBRANE, MITOCHONDRION, TRANSIT PEPTIDE, TRANSPORT, PHOSPHOPROTEIN, HEME, IRON, METAL-BINDING, IRON-SULFUR, OXIDOREDUCTASE, METHYLATION 
3cxh:V     (ILE2) to   (ILE106)  STRUCTURE OF YEAST COMPLEX III WITH ISOFORM-2 CYTOCHROME C BOUND AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.  |   COMPLEX III, CYTOCHROME C ISOFORM-2, ELECTRON TRANSFER COMPLEX, CYTOCHROME BC1 COMPLEX, MITOCHONDRIALTRANSMEMBRANE COMPLEX, RESPIRATORY CHAIN, TRANSIENT PROTEIN-PROTEIN INTERACTION, ELECTRON TRANSPORT, INNER MEMBRANE, MITOCHONDRION, TRANSIT PEPTIDE, TRANSPORT, PHOSPHOPROTEIN, HEME, IRON, METAL-BINDING, IRON-SULFUR, OXIDOREDUCTASE 
4cni:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6  |   IMMUNE SYSTEM,  CDP6038, INTERLEUKIN 6 
4rzc:L     (VAL3) to   (SER107)  FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE  |   ANTIBODY VARIABLE FRAGMENT, MANNOSE-6-PHOSPHATE, IMMUNE SYSTEM 
4tqe:L     (VAL2) to   (ILE111)  STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT  |   INTRINSICALLY DISORDERED PROTEIN, IMMUNE SYSTEM 
4tul:L     (VAL2) to   (LEU112)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   IMMUNE SYSTEM, NEUROBLASTOMA 
4tuo:B     (VAL2) to   (LEU112)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   NEUROBLASTOMA, IMMUNE SYSTEM 
5hhv:L     (ASN1) to   (VAL106)  INHIBITING COMPLEX IL-17A AND IL-17RA INTERACTIONS WITH A LINEAR PEPTIDE  |   IL-17, INFLAMMATION, INHIBITOR, COMPLEX CRYSTAL STRUCTURE, IMMUNE SYSTEM-INHIBITOR COMPLEX 
4u6h:B     (VAL2) to   (ALA114)  VACCINIA L1/M12B9-FAB COMPLEX  |   IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN 
4uil:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1 WITH QUININE  |   IMMUNE SYSTEM, FAB, QUININE-DEPENDENT, MOUSE MAB 
4uin:L     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3 WITH QUININE  |   IMMUNE SYSTEM, QUININE-DEPENDENT, MOUSE MAB 
3pnw:V     (ILE3) to   (ILE109)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
4ers:L     (ASP1) to   (ILE106)  A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR  |   GLUCAGON RECEPTOR, CLASS-B GPCR, FAB, GLYCOSYLATION, EXTRA-CELLULAR, IMMUNE SYSTEM 
3qcv:L     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)  |   ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM 
3qcv:M     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)  |   ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM 
5jof:L     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.  |   HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM 
5jxe:C     (GLU1) to   (ILE110)  HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB  |   HUMAN PD-1 PEMBROLIZUMAB FAB, IMMUNE SYSTEM 
5kov:C  (ASP1001) to  (ILE1106)  CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 CAPSID PROTEIN SPIKE IN COMPLEX WITH A SINGLE CHAIN VARIABLE FRAGMENT OF AN ASTROVIRUS NEUTRALIZING ANTIBODY AT 3.24-A RESOLUTION  |   VIRAL PROTEIN, CAPSID PROTEIN, ICOSAHEDRAL VIRUS, SINGLE CHAIN VARIABLE FRAGMENT. 
5kov:K  (ASP1001) to  (ILE1106)  CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 CAPSID PROTEIN SPIKE IN COMPLEX WITH A SINGLE CHAIN VARIABLE FRAGMENT OF AN ASTROVIRUS NEUTRALIZING ANTIBODY AT 3.24-A RESOLUTION  |   VIRAL PROTEIN, CAPSID PROTEIN, ICOSAHEDRAL VIRUS, SINGLE CHAIN VARIABLE FRAGMENT. 
5kov:U  (ASP1001) to  (ILE1106)  CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 CAPSID PROTEIN SPIKE IN COMPLEX WITH A SINGLE CHAIN VARIABLE FRAGMENT OF AN ASTROVIRUS NEUTRALIZING ANTIBODY AT 3.24-A RESOLUTION  |   VIRAL PROTEIN, CAPSID PROTEIN, ICOSAHEDRAL VIRUS, SINGLE CHAIN VARIABLE FRAGMENT. 
5t5n:N     (ILE2) to   (VAL106)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM  |   ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN 
5te4:L     (TYR1) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE G STRAIN X2088 GP120 CORE  |   HIV-1, VRC01-CLASS ANTIBODY, N6, CD4-BINDING SITE, GP120, IMMUNE SYSTEM 
6fab:L     (GLN3) to   (ILE106)  THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P- AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY, SITE-DIRECTED MUTAGENESIS, AND MODELING OF THE COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN 
1a7n:L     (ASP1) to   (ILE106)  FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL  |   IMMUNOGLOBULIN, VARIANT 
3eo1:A     (THR2) to   (ILE107)  STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3  |   ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX 
3eo1:G     (THR2) to   (ILE107)  STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3  |   ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX 
2bdn:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY, 11K2  |   ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
4hg4:K     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1bre:F     (ILE2) to   (ILE106)  IMMUNOGLOBULIN LIGHT CHAIN PROTEIN  |   IMMUNOGLOBULIN 
4xc3:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE  |   HIV-1 GP41 MPER, 4E10 FAB, MEMBRANE LIPID, IMMUNE SYSTEM 
4xcy:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
4xcy:B     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
4xcy:D     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
4xcy:F     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
2c1o:A     (LEU2) to   (LEU106)  ENAIIHIS FAB FRAGMENT IN THE FREE FORM  |   FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENA11HIS ANTIBODY, IMMUNOGLOBULIN DOMAIN 
1d5b:A     (ILE2) to   (ILE106)  UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY  |   IMMUNE SYSTEM 
1d5b:L     (ILE2) to   (ILE106)  UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY  |   IMMUNE SYSTEM 
1p84:K     (GLU3) to   (ILE106)  HDBT INHIBITED YEAST CYTOCHROME BC1 COMPLEX  |   CYTOCHROME BC1 COMPLEX, COMPLEX III, UBIQUINOL, CYTOCHROME C OXIDOREDUCTASE, HYDROXYQUINONE, HHDBT, QO SITE, PHOSPHOLIPID, MEMBRANE PROTEIN 
2ddq:L     (LEU3) to   (LEU111)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT  |   MONOCLONAL ANTIBODY, 4-HYDROXY-2-NONENAL, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4jn1:L     (VAL3) to   (ILE112)  AN ANTIDOTE FOR DABIGATRAN  |   IGG FRAGMENT BINDING DABIGATRAN, IMMUNE SYSTEM 
2vir:A     (ALA2) to   (LEU109)  INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (HEMAGGLUTININ/IMMMUNOGLOBULIN), GLYCOPROTEIN 
3v4v:L     (VAL2) to   (ILE111)  CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376  |   CELL ADHESION, MADCAM-1, MEMBRANE 
3vi3:E     (ASP1) to   (LEU111)  CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)  |   BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX 
4zxb:D     (ILE2) to   (ILE106)  STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES  |   RECEPTOR TYROSINE KINASE EXTRACELLULAR DOMAIN ANTIBODY FRAGMENTS, HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
1tqb:C     (VAL2) to   (ILE106)  OVINE RECOMBINANT PRP(114-234), VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY  |   PRION, ANTIBODY, UNKNOWN FUNCTION/IMMUNE SYSTEM COMPLEX 
1igi:L     (VAL2) to   (ILE106)  26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY  |   IMMUNOGLOBULIN 
4m7j:L     (ILE2) to   (LEU106)  CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE  |   BETA-SANDWICH, CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
5c9k:D     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
1mrd:L     (VAL3) to   (ILE106)  PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES  |   IMMUNOGLOBULIN 
4plk:C     (ILE2) to   (ILE106)  HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12  |   COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4q9r:L     (ILE3) to   (ILE107)  CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO TRIFLUOROETHYL-LIGAND ANALOG IN COMPLEX WITH FAB  |   G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE, RNA-IMMUNE SYSTEM COMPLEX 
2a6k:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR  |   IMMUNOGLOBULIN FOLD, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
2a6k:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR  |   IMMUNOGLOBULIN FOLD, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
3cfe:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
5ggt:L     (ILE2) to   (ILE105)  PD-L1 IN COMPLEX WITH BMS-936559 FAB  |   ANTIBODY, IMMUNE SYSTEM 
5grw:B   (ILE125) to   (GLU229)  CRYSTAL STRUCTURE OF HOMO-SPECIFIC DIABODY  |   DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM 
3piq:I     (VAL3) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1  |   MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM 
3qcu:L     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)  |   ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM 
3qg7:L     (VAL2) to   (ILE106)  STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY  |   IMMUNOGLOBULIN FOLD, ANTIGEN RECOGNITION, AIP4, SECRETED, IMMUNE SYSTEM